ER-21027

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameER-21027

Drug Alias NameER-21027

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2b (5-HT2b) receptor antagonists

TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2a (5-HT2a) receptor

Therapy Area/IndicationsHematologic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEurapharm Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEurapharm Inc

Active IndicationsN/A

Inactive IndicationsHematologic Diseases

ATC CodeN/A